Is CBOP/BEP an alternative to BEP for patients with poor prognosis metastatic germ cell tumours?

被引：0
|
作者：
Addeo, A. [1 ]
Fusco, V. [2 ]
Braybrooke, J. P. [1 ]
机构：
[1] Univ Hosp Bristol NHS Fdn Trust, Bristol Canc Inst, Bristol, Avon, England
[2] SS Antonio & Biagio & Cesare Arrigo Hosp, Oncol Unit, Alessandria, Italy
来源：
ESMO OPEN | 2016年 / 1卷 / 04期
关键词：
D O I：
10.1136/esmoopen-2016-000089
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] CBOP/BEP chemotherapy for intermediate and poor prognosis patients and relapsed patients with germ cell tumours
    Mitra, SS
    Barber, J
    Mason, MD
    Allan, D
    Savage, P
    BRITISH JOURNAL OF CANCER, 1999, 80 : 109 - 109
  • [2] Intensive induction chemotherapy with CBOP/BEP in patients with poor prognosis germ cell tumors
    Christian, JA
    Huddart, RA
    Norman, A
    Mason, M
    Fossa, S
    Aass, N
    Nicholl, EJ
    Dearnaley, DP
    Horwich, A
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (05) : 871 - 877
  • [3] CBOP/BEP accelerated induction chemotherapy in poor prognosis germ cell tumours (GCT). The Royal Marsden Hospital Experience.
    Bonar, J
    Huddart, R
    Norman, A
    Nicholls, J
    Dearnaley, D
    Horwich, A
    ANNALS OF ONCOLOGY, 2000, 11 : 74 - 74
  • [4] Accelerated BEP: a phase I trial of dose-dense BEP for intermediate and poor prognosis metastatic germ cell tumour
    Rimmer, Y.
    Chester, J.
    Joffe, J.
    Stark, D.
    Shamash, J.
    Powles, T.
    White, J.
    Wason, J.
    Parashar, D.
    Armstrong, G.
    Mazhar, D.
    Williams, M. V.
    BRITISH JOURNAL OF CANCER, 2011, 105 (06) : 766 - 772
  • [5] Accelerated BEP: a phase I trial of dose-dense BEP for intermediate and poor prognosis metastatic germ cell tumour
    Y Rimmer
    J Chester
    J Joffe
    D Stark
    J Shamash
    T Powles
    J White
    J Wason
    D Parashar
    G Armstrong
    D Mazhar
    M V Williams
    British Journal of Cancer, 2011, 105 : 766 - 772
  • [6] A Randomised Phase 2 Trial of Intensive Induction Chemotherapy (CBOP/BEP) and Standard BEP in Poor-prognosis Germ Cell Tumours (MRC TE23, CRUK 05/014, ISRCTN 53643604)
    Huddart, Robert A.
    Gabe, Rhian
    Cafferty, Fay H.
    Pollock, Philip
    White, Jeff D.
    Shamash, Jonathan
    Cullen, Michael H.
    Stenning, Sally P.
    EUROPEAN UROLOGY, 2015, 67 (03) : 534 - 543
  • [7] BEP versus EP for treatment of metastatic germ-cell tumours
    Jankilevich, G
    LANCET ONCOLOGY, 2004, 5 (03): : 146 - 146
  • [8] Paclitaxel plus BEP (T-BEP) Regimen as Induction Chemotherapy in Poor Prognosis Patients With Nonseminomatous Germ Cell Tumors: A Phase II Study
    Tryakin, A.
    Fedyanin, M.
    Kanagavel, D.
    Fainstein, I.
    Sergeev, J.
    Polockij, B.
    Matveev, V.
    Zakharova, T.
    Garin, A.
    Tjulandin, S.
    UROLOGY, 2011, 78 (03) : 620 - 625
  • [9] A randomized phase II trial of intensive induction chemotherapy (CBOP/BEP) and standard BEP in poor prognosis germ cell tumors (MRC TE23, CRUK 05/014, ISRCTN53643604).
    Huddart, R. A.
    Gabe, R.
    Cafferty, F.
    Pollock, P.
    White, J. D.
    Shamash, J.
    Stenning, S. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [10] THE ANZUP PHASE 3 ACCELERATED BEP TRIAL: A RANDOMISED PHASE 3 TRIAL OF ACCELERATED VERSUS STANDARD BEP CHEMOTHERAPY FOR PATIENTS WITH INTERMEDIATE AND POOR-RISK METASTATIC GERM CELL TUMOURS
    Long, A.
    Toner, G. C.
    Stockler, M.
    Thompson, D. B.
    Gebski, V.
    Yip, S.
    King, M.
    Friedlander, M.
    Quinn, D.
    Singhal, N.
    Roncolato, F.
    Grimison, P. S.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 : 61 - 62
12345